Why the study?
Does dietary omega-3 fatty acid supplementation prolong platelet survival in hyperlipidemic patients with established atherothrombotic disorders?
Population
Hyperlipidemic patients with preexisting, established atherothrombotic disorders
Design
Cohort
Follow-up
6 weeks
Authors
Loading...
Should not yet change practice in hyperlipidemic patients; leaves open whether prolonged platelet survival reduces atherothrombotic events.
Does dietary omega-3 fatty acid supplementation prolong platelet survival in hyperlipidemic patients with established atherothrombotic disorders?
Dietary omega-3 fatty acid supplementation prolongs platelet survival, indicating suppressed in vivo platelet activity, in hyperlipidemic patients with atherosclerosis.
Peter H. Levine (1989) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: